CLINICAL_TRIALS
trial_result
· 2025-10-03
Clinical Trial Update: 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer [EARLY_Phase 1]
Summary
The study investigates two radiopharmaceuticals, 177Lu-P17-087 and 177Lu-P17-088, in patients with metastatic castration-resistant prostate cancer. It is an ear…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Metastatic Castration-resistant Prostate Cancer | EARLY_Phase 1 | Status: RECRUITING